Virvio Company

Developer of a broadly-protective influenza therapeutic.

Last Funding Type: Grant
Headquarters: Seattle, Washington, United States
Founded Date: 2015-12-01
Last Funding Date: 2016-02-15
Total Funding: 209000.0
Technology: Early Drug Development
Employee Number: 1-10
Estimated Revenue: Less than $1M
Investors Number: 1.0
Industry: Early Drug Development